OncoLink Cancer Treatment and Resources

Tumor Marker for Breast Cancer

Last Modified: June 18, 2009

Question

Dear OncoLink "Ask The Experts,"
The Ca 27-29 blood test has a “normal” level below 30. Is it possible for the level to reach zero in a person who had invasive cancer with no lymph node involvement?

Answer

Suzanne M. McGettigan, MSN, CRNP, AOCN, Board Certified Adult Nurse Practitioner and a Certified Oncology Advanced Practice Nurse, responds:

A tumor marker is a substance that is produced by the body in response to cancer, or is produced by the cancer itself. Some of these markers are specific to one cancer, while others are seen in several types of cancer. These markers are generally used to evaluate the patient's response to treatment or to monitor for recurrence (return of the cancer after treatment). There are non-cancerous conditions that can cause markers to be elevated, so these must also be considered when interpreting the test results. Tumor markers can be used in conjunction with other tests (scans, biopsies, etc.) to help diagnose a patient who has symptoms suspicious for cancer. Some markers can help physicians to determine prognosis and treatment.

The CA 27-29 is a tumor marker that is most often used in people with breast cancer. In general, the number is not elevated in people with early stage cancers. If someone had an isolated recurrence that resulted in an elevated level and the tumor was surgically removed, the CA 27-29 could go to zero, or within normal range, after surgery.

In metastatic cancer, the CA 27-29 level does not ever go down to zero, but it can dip back into the normal range. More than the actual number, we follow trends of the marker to see if it is going up or down, or remaining stable. The result may be used in conjunction with radiology studies if recurrence or progression is suspected.

This test is far from perfect, as some women with metastatic disease never have an elevation in the tumor markers. Benign conditions, such as ovarian cysts, fibroids, liver and kidney disorders, and benign breast problems can result in elevated CA 27-29 levels. It can take 1-3 months after starting a new treatment for results to begin to decrease, so we typically wait 2-3 months to recheck CA 27-29.

OncoLink I wish u knew...

Learning as much as you can about your cancer diagnosis gives you the tools you need to make treatment decisions. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS